Starts in
000
days
00
hours
00
minutes
00
seconds
Welcome to Precision Medicine and the Future of Genomics 2024 Summit
We are thrilled to extend a warm welcome to all participants, partners and supporters in the realm of healthcare innovation and research. As Chairs for this year’s summit, we are delighted to mark a significant milestone in the journey of precision medicine, as we celebrate a decade of precision medicine and its applications from bench to bedside.
We are immensely proud to be the first healthcare organization in the Middle East to lead a symposium dedicated to precision medicine, since launching our PMFG series in 2014. Over the past nine years, our conference and has grown to become a hub for thought leaders, researchers, scientists, clinicians, technologists and innovators on how precision medicine has become a reality.
Our 10th anniversary PMFG 2024 will celebrate the successes of precision medicine and its solutions. PMFG 2024 is scheduled to take place from December 3rd to 5th, 2024, at the Qatar National Convention Center (QNCC) in Doha, Qatar.
The objectives at PMFG 2024 are centered around three crucial domains serving as the foundation for achieving meaningful outcomes for our patients and their families: Genomics for All, Precision Diagnostics in Rare and Complex Diseases and Advanced Therapeutics in Precision Medicine.
We are confident that the insightful discussions, presentations, and collaborations during the summit will pave the way for transformative advancements in the field.
Thank you for joining us on this exciting journey at PMFG 2024. See you in Doha!
Best regards,
Dr. Ammira Al-Shabeeb Akil and Dr. Khalid Fakhro
PMFG 2024 Summit Organizing Chairs
Summit Organizing Chairs
Empowering Tomorrow’s Health: Unveiling the Boundless Potential of Precision Medicine through Collaboration, Innovation, and Future Genomic Discoveries at PMFG 2024
Genomics for All: Screening From Newborns to Whole Population
- Develop and establish robust genomic screening initiatives for newborns to identify and address potential genetic conditions early in life.
- Evaluate Population-wide Genomic Data for Precision Medicine from population cohorts to enhance our understanding of genetic variations, susceptibility to diseases, and potential targets for precision medicine interventions.
- Discuss the potential impact of early genomic information on long-term health outcomes.
Precision Diagnostics in Rare and Complex Diseases
- Develop and implement advanced diagnostic technologies to improve the accuracy and efficiency of identifying rare and complex diseases at an early stage.
- Encourage the exploration and development of targeted therapies and precision interventions tailored to the unique genetic and molecular profiles associated with rare and complex diseases.
Next-Generation Therapeutics for Precision Medicine
- Showcase and discuss the latest advancements in personalized and precision therapies, including innovative treatment modalities, targeted therapies, and emerging technologies.
- Explore groundbreaking research and clinical trials that demonstrate the potential for customized treatment strategies to improve outcomes for individuals with rare and complex diseases. Emphasize the importance of staying abreast of cutting-edge developments to inform clinical practice and enhance patient care.
- Emphasize the integration of genomic data into clinical practice, fostering a deeper understanding of the genetic underpinnings of complex diseases and paving the way for more targeted and effective interventions.
Healthcare Professionals:
- Physicians
- Nurses
- Geneticists
- Researchers
- Clinicians
Scientists and Researchers:
- Genomic scientists
- Biomedical researchers
- Bioinformaticians
- Researchers in precision medicine
Industry Leaders:
- Professionals from pharmaceutical and biotechnology companies
- Executives and decision-makers in healthcare organizations
Academic Institutions:
- Faculty members
- Students in healthcare, genetics, and related fields
Policy Makers and Regulators:
- Government officials involved in healthcare policy
- Regulatory authorities
Technology and Solution Providers:
- Companies offering genomic sequencing technologies
- Biotech and healthcare IT companies
Patient Advocates:
- Representatives from patient advocacy groups
- Individuals interested in advancements in precision medicine for patient care
International Delegates:
- Professionals and researchers from around the world interested in precision medicine advancements
The objectives aim to align with the pillars outlined in the summit program, emphasizing innovation, collaboration, and ethical considerations within the domains of newborn sequencing, population genomic screening, and advanced therapeutics in precision medicine.
- Elucidate advancements in newborn sequencing technologies, addressing implementation challenges and fostering discussions on best practices.
- Explore the potential long-term health impact of early genomic information, emphasizing the importance of early intervention and personalized care for newborns.
- Explore cutting-edge innovations in population screening, keeping attendees informed about large-scale genomic advancements.
- Investigate integrating genomic data into population health management, discuss effective utilization strategies within healthcare systems, and foster ethical conversations on large-scale genomic screening responsibly.
- Spotlight cutting-edge developments in personalized and precision therapies, showcasing the latest advancements contributing to more effective and targeted treatments.
- Facilitate discussions on the role of genomics in tailoring treatment plans for complex diseases, exploring how genomic insights can enhance therapeutic decision-making.
Conference Pillars
Genomics for All: Screening From Newborns to Whole Population
- Develop and establish robust genomic screening initiatives for newborns to identify and address potential genetic conditions early in life.
- Evaluate Population-wide Genomic Data for Precision Medicine from population cohorts to enhance our understanding of genetic variations, susceptibility to diseases, and potential targets for precision medicine interventions.
- Discuss the potential impact of early genomic information on long-term health outcomes.
Precision Diagnostics in Rare and Complex Diseases
- Develop and implement advanced diagnostic technologies to improve the accuracy and efficiency of identifying rare and complex diseases at an early stage.
- Encourage the exploration and development of targeted therapies and precision interventions tailored to the unique genetic and molecular profiles associated with rare and complex diseases.
Next-Generation Therapeutics for Precision Medicine
- Showcase and discuss the latest advancements in personalized and precision therapies, including innovative treatment modalities, targeted therapies, and emerging technologies.
- Explore groundbreaking research and clinical trials that demonstrate the potential for customized treatment strategies to improve outcomes for individuals with rare and complex diseases. Emphasize the importance of staying abreast of cutting-edge developments to inform clinical practice and enhance patient care.
- Emphasize the integration of genomic data into clinical practice, fostering a deeper understanding of the genetic underpinnings of complex diseases and paving the way for more targeted and effective interventions.
Target Audience
Healthcare Professionals:
- Physicians
- Nurses
- Geneticists
- Researchers
- Clinicians
Scientists and Researchers:
- Genomic scientists
- Biomedical researchers
- Bioinformaticians
- Researchers in precision medicine
Industry Leaders:
- Professionals from pharmaceutical and biotechnology companies
- Executives and decision-makers in healthcare organizations
Academic Institutions:
- Faculty members
- Students in healthcare, genetics, and related fields
Policy Makers and Regulators:
- Government officials involved in healthcare policy
- Regulatory authorities
Technology and Solution Providers:
- Companies offering genomic sequencing technologies
- Biotech and healthcare IT companies
Patient Advocates:
- Representatives from patient advocacy groups
- Individuals interested in advancements in precision medicine for patient care
International Delegates:
- Professionals and researchers from around the world interested in precision medicine advancements
Conference Objectives
The objectives aim to align with the pillars outlined in the summit program, emphasizing innovation, collaboration, and ethical considerations within the domains of newborn sequencing, population genomic screening, and advanced therapeutics in precision medicine.
- Elucidate advancements in newborn sequencing technologies, addressing implementation challenges and fostering discussions on best practices.
- Explore the potential long-term health impact of early genomic information, emphasizing the importance of early intervention and personalized care for newborns.
- Explore cutting-edge innovations in population screening, keeping attendees informed about large-scale genomic advancements.
- Investigate integrating genomic data into population health management, discuss effective utilization strategies within healthcare systems, and foster ethical conversations on large-scale genomic screening responsibly.
- Spotlight cutting-edge developments in personalized and precision therapies, showcasing the latest advancements contributing to more effective and targeted treatments.
- Facilitate discussions on the role of genomics in tailoring treatment plans for complex diseases, exploring how genomic insights can enhance therapeutic decision-making.
Welcome to Doha, Qatar’s ultramodern capital. Located in the east of the country, Doha is home to approximately 646,000 people from all over the world. It’s the country’s fastest-growing city and its business centre.
Doha’s tourism sector has evolved rapidly over the years, with key attractions and several museums of great importance gaining the spotlight.
Known for its exemplary hospitality, exquisite cuisine, unique shopping experiences and traditional souqs, along with a plethora of adventures and activities, Doha is growing rapidly, and offers something for all travellers.
Qatar Tourism
Welcome to Doha, Qatar’s ultramodern capital. Located in the east of the country, Doha is home to approximately 646,000 people from all over the world. It’s the country’s fastest-growing city and its business centre.
Doha’s tourism sector has evolved rapidly over the years, with key attractions and several museums of great importance gaining the spotlight.
Known for its exemplary hospitality, exquisite cuisine, unique shopping experiences and traditional souqs, along with a plethora of adventures and activities, Doha is growing rapidly, and offers something for all travellers.